BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gasca J, Flores ML, Jiménez-Guerrero R, Sáez ME, Barragán I, Ruíz-Borrego M, Tortolero M, Romero F, Sáez C, Japón MA. EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells. Cell Death Discov 2020;6:86. [PMID: 33014430 DOI: 10.1038/s41420-020-00322-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao S, Tang Y, Wang R, Najafi M. Mechanisms of cancer cell death induction by paclitaxel: an updated review. Apoptosis 2022. [PMID: 35849264 DOI: 10.1007/s10495-022-01750-z] [Reference Citation Analysis]
2 Lin Z, Jiang C, Lv D, Lin D. Identification of EDIL3 biomarkers as a biomarker and potential therapeutic target of canine mammary carcinomas based on integrated bioinformatics analysis. Veterinary Immunology and Immunopathology 2022;249:110432. [DOI: 10.1016/j.vetimm.2022.110432] [Reference Citation Analysis]
3 Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol 2022;15:18. [PMID: 35236381 DOI: 10.1186/s13045-022-01235-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
4 Pan X, Yi M, Liu C, Jin Y, Liu B, Hu G, Yuan X. Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model. Bioengineered 2022;13:4557-72. [PMID: 35142593 DOI: 10.1080/21655979.2022.2029236] [Reference Citation Analysis]
5 Rastogi T, Girerd N, Lamiral Z, Bresso E, Bozec E, Boivin J, Rossignol P, Zannad F, Ferreira JP. Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.02.017] [Reference Citation Analysis]
6 Filipa Cruz A, Fonseca NA, Rita Malheiro A, Melo JB, Manuela Gaspar M, Fernandes R, Moura V, Simões S, Nuno Moreira J. Targeted liposomal doxorubicin/ceramides combinations: the importance to assess the nature of drug interaction beyond bulk tumor cells. Eur J Pharm Biopharm 2022:S0939-6411(22)00012-1. [PMID: 35104605 DOI: 10.1016/j.ejpb.2022.01.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Simancas Escorcia V, Guillou C, Abbad L, Derrien L, Rodrigues Rezende Costa C, Cannaya V, Benassarou M, Chatziantoniou C, Berdal A, Acevedo AC, Cases O, Cosette P, Kozyraki R. Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach. Front Endocrinol (Lausanne) 2021;12:752568. [PMID: 34777248 DOI: 10.3389/fendo.2021.752568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu YP, Zheng CC, Huang YN, He ML, Xu WW, Li B. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm (2020) 2021;2:315-40. [PMID: 34766149 DOI: 10.1002/mco2.55] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ganini C, Amelio I, Bertolo R, Candi E, Cappello A, Cipriani C, Mauriello A, Marani C, Melino G, Montanaro M, Natale ME, Tisone G, Shi Y, Wang Y, Bove P. Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00440-7] [Reference Citation Analysis]
10 Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh SO, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar AP, Aref AR, Samarghandian S. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother 2021;141:111824. [PMID: 34175815 DOI: 10.1016/j.biopha.2021.111824] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
11 Gao L, Wu ZX, Assaraf YG, Chen ZS, Wang L. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function. Drug Resist Updat 2021;57:100770. [PMID: 34175687 DOI: 10.1016/j.drup.2021.100770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
12 Singh AK, Cai C, Kilari S, Zhao C, Simeon ML, Takahashi E, Edelman ER, Kong HJ, Macedo T, Singh RJ, Urban MW, Kumar R, Misra S. 1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas. J Am Soc Nephrol 2021:ASN. [PMID: 33627344 DOI: 10.1681/ASN.2020060832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]